Abstract
The method for preventing progression to metabolic syndrome includes determining whether a subject possesses at least one allele of the caveolin-1 rs1997623 C to A SNP, and providing an intervention to prevent progression to metabolic syndrome, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with MetS, such as heart disease, stroke, or diabetes. The method may include monitoring additional metabolic risk factors. The pharmaceutical compound may be a pharmaceutical capable of inhibiting the expression of caveolin-1.
| Original language | English |
|---|---|
| Patent number | 10,731,219, B1 |
| IPC | US |
| Filing date | 19/09/19 |
| Publication status | Published - 4 Aug 2020 |
Keywords
- Metabolic syndrome